AI Powered Alternatives to Antibiotics

Digital Therapeutix: Advancing the Fight Against Antibiotic Resistance

Digital Therapeutix leverages the precision of bacteriophages and the intelligence of AI to deliver more innovative solutions for microbial threats.

Designed with input from practicing physicians and medical experts

Designed with input from practicing physicians and medical experts

Our Clients

Our Mission

Solving Antimicrobial Resistance, One Bacteriophage at a Time

We are scientists, engineers, clinicians, and leaders with deep expertise in life sciences, AI, digital systems, and public health, united by a shared mission to make innovation matter where it counts most: in real impact for real lives.

Smart Science Smart Science Smart Science Smart Science Smart Science Smart Science Smart Science Smart Science

Real Impact Real Impact Real Impact Real Impact Real Impact Real Impact

Trust in Number

The Global Threat We're Fighting. Together.

1.27 M

Global deaths from AMR each year.

35%

Common infections now resist primary antibiotics.

$100T

Estimated global economic cost by 2050 if AMR is unchecked.

>95%

Match Accuracy with Quint

Trust in Number

Our 3 Pillars: Global Solutions for a Healthier World

Our Team

Meet Our Team of Experts

News and media

Explore our news & media

Frequently Asked Question

What is Page Therapy and how does it work?
Phage Therapy uses naturally occurring viruses, called bacteriophages, to find and destroy harmful bacteria. Unlike antibiotics, phages are precise; they target only the “bad” bacteria and leave the rest of the body’s good bacteria untouched.
Phage Therapy saves time and costs by precisely targeting harmful bacteria, reducing the need for trial-and-error treatments, and minimizing hospital stays. This focused approach reduces complications and resistance, resulting in faster recovery and significant long-term savings.
Phage Therapy is ideal for small clinics because it can be delivered through targeted treatments without requiring extensive infrastructure. With AI support, clinicians can quickly match the right phage, making it practical, affordable, and accessible for smaller care settings.